$CBIS "We are very pleased to hear the DEA's decis

$CBIS "We are very pleased to hear the DEA's decision to review marijuana's drug classification scheduling. It is clear to us and to so many others that the natural drug offers a host of health benefits and treatment properties. Cannabis Science will benefit extraordinarily as our research is already on the cutting edge, this Landmark move will open the industry in leaps and bounds," said Cannabis Science Inc. President, CEO & Co-Founder Raymond C. Dabney.

http://tinyurl.com/hsgbykw

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!